D'Onofrio Matthew J 4
4 · Evoke Pharma Inc · Filed Dec 11, 2020
Insider Transaction Report
Form 4
Evoke Pharma IncEVOK
D'Onofrio Matthew J
Exec VP, Chief Bus. Officer
Transactions
- Exercise/Conversion
Common Stock
2020-12-09$0.40/sh+46,000$18,400→ 329,997 total - Exercise/Conversion
Stock Option (Right to Buy)
2020-12-09−46,000→ 0 totalExercise: $0.40Exp: 2021-02-09→ Common Stock (46,000 underlying)
Footnotes (2)
- [F1]These options were scheduled to expire on February 9, 2021.
- [F2]These options were fully vested as of February 9, 2015.